Visual Function After Bilateral Implantation of AcrySof® Toric
NCT ID: NCT00758550
Last Updated: 2010-03-16
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
60 participants
INTERVENTIONAL
2007-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Visual Function After Implantation of Bilateral AcrySof® Toric Natural Intraocular Lens
NCT00760487
AcrySof Toric Clinical Results
NCT01214863
Rotational Stability of the AcrySof® Toric
NCT00762216
Visual Function With Bilateral AcrySof® ReSTOR® Aspheric SN6AD1
NCT00710931
Visual Function After Implantation of AcrySof® Toric Lens
NCT01074606
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
AcrySof Natural IOL
AcrySof Natural Intraocular Lens (IOL)
AcrySof Natural
AcrySof Natural Intraocular Lens (IOL) implanted into the study eye following cataract extraction surgery
AcrySof Toric IOL
AcrySof Toric Intraocular Lens (IOL)
AcrySof® Toric IOL
AcrySof® Toric Intraocular Lens (IOL) implanted into the study eye following cataract extraction surgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
AcrySof® Toric IOL
AcrySof® Toric Intraocular Lens (IOL) implanted into the study eye following cataract extraction surgery
AcrySof Natural
AcrySof Natural Intraocular Lens (IOL) implanted into the study eye following cataract extraction surgery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 40\~80 years of age
* 4 Days - 1 Week interval between a single patient's surgery
* dilated pupil size (in dim light) ≥ 4.0 mm
* Anticipated correction with an IOL of +10 Diopters \~ +25 Diopters
* 0.75 - 2.0 Diopters of astigmatism preoperatively as measured by Keratometry readings
Exclusion Criteria
* Previous intraocular or corneal surgery
* An increased risk for complications which could require vitreoretinal surgery
* Corneal irregularities
* Corneal opacities
* Current contact lens usage(within 6 months prior to first surgery)
40 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alcon Research
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Alcon Research Ltd.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Alcon Call Center
Fort Worth, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CM-06-17
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.